Targeting MET Exon 14 Skipping Alterations: Has Lung Cancer MET Its Match?

被引：6

作者：

Yap, Timothy A. ^{[1
,2
]}

Popat, Sanjay ^{[1
,3
]}

机构：

[1] Royal Marsden Hosp, London, England

[2] Inst Canc Res, London, England

[3] Imperial Coll London, Natl Heart & Lung Inst, London, England

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

ACQUIRED-RESISTANCE; AMPLIFICATION; INHIBITORS; MUTATIONS; CARCINOMA;

D O I：

10.1016/j.jtho.2016.10.019

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：12 / 14

页数：3

共 50 条

[1] MET Exon 14 Alterations in Lung Cancer: Exon Skipping Extends Half-Life
Drilon, Alexander
CLINICAL CANCER RESEARCH, 2016, 22 (12) : 2832 - 2834
[2] Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations
Schrock, Alexa B.
Frampton, Garrett M.
Suh, James
Chalmers, Zachary R.
Rosenzweig, Mark
Erlich, Rachel L.
Halmos, Balazs
Goldman, Jonathan
Forde, Patrick
Leuenberger, Kurt
Peled, Nir
Kalemkerian, Gregory P.
Ross, Jeffrey S.
Stephens, Philip J.
Miller, Vincent A.
Ali, Siraj M.
Ou, Sai-Hong Ignatius
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (09) : 1493 - 1502
[3] Histological characteristics of lung adenocarcinoma with uncommon actionable alterations: special emphasis on MET exon 14 skipping alterations
Hayashi, Takuo
Kohsaka, Shinji
Takamochi, Kazuya
Kishikawa, Satsuki
Ikarashi, Daiki
Sano, Kei
Hara, Kieko
Onagi, Hiroko
Suehara, Yoshiyuki
Takahashi, Fumiyuki
Saito, Tsuyoshi
Nakatsura, Tetsuya
Kitano, Shigehisa
Suzuki, Kenji
Yao, Takashi
HISTOPATHOLOGY, 2021, 78 (07) : 987 - 999
[4] Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With MET Exon 14 Skipping
Hur, Joon Young
Ku, Bo Mi
Shim, Joon Ho
Jung, Hyun Ae
Sun, Jong-Mu
Lee, Se-Hoon
Ahn, Jin Seok
Park, Keunchil
Ahn, Myung-Ju
IN VIVO, 2020, 34 (03): : 1399 - 1406
[5] Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
Paik, Paul K.
Felip, Enriqueta
Veillon, Remi
Sakai, Hiroshi
Cortot, Alexis B.
Garassino, Marina C.
Mazieres, Julien
Viteri, Santiago
Senellart, Helene
Van Meerbeeck, Jan
Raskin, Jo
Reinmuth, Niels
Conte, Pierfranco
Kowalski, Dariusz
Cho, Byoung Chul
Patel, Jyoti D.
Horn, Leora
Griesinger, Frank
Han, Ji-Youn
Kim, Young-Chul
Chang, Gee-Chen
Tsai, Chen-Liang
Yang, James C. -H.
Chen, Yuh-Min
Smit, Egbert F.
van der Wekken, Anthonie J.
Kato, Terufumi
Juraeva, Dilafruz
Stroh, Christopher
Bruns, Rolf
Straub, Josef
Johne, Andreas
Scheele, Juergen
Heymach, John V.
Le, Xiuning
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (10) : 931 - 943
[6] Non-small-cell lung cancer: how to manage MET exon 14 skipping mutant disease
Blaquier, Juan Bautista
Recondo, Gonzalo
DRUGS IN CONTEXT, 2022, 11
[7] MET exon 14 skipping mutations and gene amplification in a Taiwanese lung cancer population
Lung, Jrhau
Hung, Ming-Szu
Lin, Yu-Ching
Lee, Kam-Fai
Jiang, Yuan Yuan
Huang, Shao-Lan
Fang, Yu-Hung
Lu, Ming-Shian
Lin, Chin-Kuo
Yang, Tsung-Ming
Lin, Paul Yann
Hsieh, Meng-Jer
Tsai, Ying Huang
PLOS ONE, 2019, 14 (08):
[8] From knowledge to action: The journey toward targeting the MET pathway via MET exon 14 skipping
Bogdanska, Wiktoria
Paik, Paul K.
CANCER, 2025, 131
[9] MET Exon 14 Skipping in Non-Small Cell Lung Cancer
Heist, Rebecca S.
Shim, Hyo Sup
Gingipally, Shalini
Mino-Kenudson, Mari
Le, Long
Gainor, Justin F.
Zheng, Zongli
Aryee, Martin
Xia, Junfeng
Jia, Peilin
Jin, Hailing
Zhao, Zhongming
Pao, Gwilliam
Engelman, Jeffrey A.
Iafrate, A. John
ONCOLOGIST, 2016, 21 (04) : 481 - 486
[10] Has MET met its match?
Borczuk, Alain
Paucar, Daniel
Halmos, Balazs
ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (05)

← 1 2 3 4 5 →